Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 116

Sort by

Sort Order Select

Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair

Blood Adv (2021) 5 (18): 3694–3708.

https://doi.org/10.1182/bloodadvances.2020003534

Published: 2021

Includes: Supplemental data

Journal Articles

A novel activating JAK1 mutation in chronic eosinophilic leukemia

William Shomali, Alisa Damnernsawad, Talent Theparee, David Sampson, Quinlan Morrow, Fei Yang, Sebastian Fernandez-Pol, Richard Press, James Zehnder, Jeffrey W. Tyner, Jason Gotlib

Blood Adv (2021) 5 (18): 3581–3586.

https://doi.org/10.1182/bloodadvances.2021004237

Published: 2021

Includes: Supplemental data

Journal Articles

Germline variants in DNA repair genes, including BRCA1 / 2 , may cause familial myeloproliferative neoplasms

Miriam Elbracht, Robert Meyer, Kim Kricheldorf, Deniz Gezer, Eggermann Thomas, Beate Betz, Ingo Kurth, Lino L. Teichmann, Tim H. Brümmendorf, Ulrich Germing, Susanne Isfort, Steffen Koschmieder

Blood Adv (2021) 5 (17): 3373–3376.

https://doi.org/10.1182/bloodadvances.2021004811

Published: 2021

Journal Articles

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis

Blood Adv (2021) 5 (16): 3163–3173.

https://doi.org/10.1182/bloodadvances.2020003829

Published: 2021

Journal Articles

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Blood Adv (2021) 5 (15): 2945–2957.

https://doi.org/10.1182/bloodadvances.2021004770

Published: 2021

Includes: Supplemental data

Journal Articles

Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis

Kang Le, Jing Sun, Hunain Khawaja, Maho Shibata, Sanjay B. Maggirwar, Mitchell R. Smith, Mamta Gupta

Blood Adv (2021) 5 (14): 2863–2878.

https://doi.org/10.1182/bloodadvances.2020003871

Published: 2021

Includes: Supplemental data

Journal Articles

A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Tomas Ø. Jensen, Lilian Kolte, Daniel El Fassi, Jens Hillingsø, Aneta Radziwon-Balicka, Robert Sebastian Soyka, Klaus Hansen, Nikolai Kirkby, Jens P. Goetze, Mikkel Gybel-Brask, Eva Birgitte Leinøe, Anne-Mette Hvas, Peter Kampmann, Jakob Stensballe

Blood Adv (2021) 5 (12): 2569–2574.

https://doi.org/10.1182/bloodadvances.2021004904

Published: 2021

Journal Articles

Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome

Chunyan Sun, Jian Xu, Bo Zhang, Haifan Huang, Lei Chen, Han Yan, Aoshuang Xu, Fei Zhao, Daijuan Huang, Liqiong Liu, Jian Li, Yu Hu

Blood Adv (2021) 5 (12): 2563–2568.

https://doi.org/10.1182/bloodadvances.2020003783

Published: 2021

Includes: Supplemental data

Journal Articles

Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring

Fei Qi, Zheng Cao, Bo Chen, Yue Chai, Jing Lin, Junyi Ye, Yuce Wei, Hao Liu, Han Han-Zhang, Xinru Mao, Xiaoli Feng, Mei Dong

Blood Adv (2021) 5 (11): 2505–2514.

https://doi.org/10.1182/bloodadvances.2020001637

Published: 2021

Includes: Supplemental data

Journal Articles

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

Eva De Smedt, Julie Devin, Catharina Muylaert, Nicolas Robert, Guilhem Requirand, Philip Vlummens, Laure Vincent, Guillaume Cartron, Ken Maes, Jerome Moreaux, Elke De Bruyne

Blood Adv (2021) 5 (9): 2325–2338.

https://doi.org/10.1182/bloodadvances.2020003217

Published: 2021

Includes: Supplemental data

Journal Articles

LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα

Kensaku Kohrogi, Shinjiro Hino, Akihisa Sakamoto, Kotaro Anan, Ryuta Takase, Hirotaka Araki, Yuko Hino, Kazutaka Araki, Tetsuya Sato, Kimitoshi Nakamura, Mitsuyoshi Nakao

Blood Adv (2021) 5 (9): 2305–2318.

https://doi.org/10.1182/bloodadvances.2020003521

Published: 2021

Includes: Supplemental data

Journal Articles

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P. M. Verkleij, Marloes E. C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper, A. Vera de Jonge, Martin Kaiser, Gareth Morgan, Amy Axel, Rengasamy Boominathan, Jocelyn Sendecki, Amy Wong, Raluca I. Verona, Pieter Sonneveld, Sonja Zweegman, Homer C. Adams, III, Tuna Mutis, Niels W. C. J. van de Donk

Blood Adv (2021) 5 (8): 2196–2215.

https://doi.org/10.1182/bloodadvances.2020003805

Published: 2021

Includes: Supplemental data

Journal Articles

The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer

Min Soon Cho, Jiasong Li, Ricardo Gonzalez-Delgado, Hani Lee, Matthew Vasquez, Tiancheng He, Yunjie He, Kai Liu, Tomoyuki Sasano, Bernd Nürnberg, Anil K. Sood, Stephen T. C. Wong, Vahid Afshar-Kharghan

Blood Adv (2021) 5 (7): 1947–1951.

https://doi.org/10.1182/bloodadvances.2020003410

Published: 2021

Includes: Supplemental data

Journal Articles

Functional characterization of PD1 + TIM3 + tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade

Mikaël Roussel, Kieu-Suong Le, Clémence Granier, Francisco Llamas Gutierrez, Etienne Foucher, Simon Le Gallou, Céline Pangault, Luc Xerri, Vincent Launay, Thierry Lamy, Eric Tartour, Daniel Olive, Thierry Fest

Blood Adv (2021) 5 (7): 1816–1829.

https://doi.org/10.1182/bloodadvances.2020003080

Published: 2021

Includes: Supplemental data

Journal Articles

Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myeloma

Harsh Parmar, Morie Gertz, Emilie Ingrid Anderson, Shaji Kumar, Taxiarchis V. Kourelis

Blood Adv (2021) 5 (7): 1797–1804.

https://doi.org/10.1182/bloodadvances.2020003857

Published: 2021

Includes: Supplemental data

Journal Articles

Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles

Blood Adv (2021) 5 (6): 1682–1694.

https://doi.org/10.1182/bloodadvances.2020002998

Published: 2021

Includes: Supplemental data

Journal Articles

A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells

David J. DiLillo, Kara Olson, Katja Mohrs, Thomas Craig Meagher, Kevin Bray, Olga Sineshchekova, Thomas Startz, Jessica Kuhnert, Marc W. Retter, Stephen Godin, Prachi Sharma, Frank Delfino, John Lin, Eric Smith, Gavin Thurston, Jessica R. Kirshner

Blood Adv (2021) 5 (5): 1291–1304.

https://doi.org/10.1182/bloodadvances.2020002736

Published: 2021

Includes: Supplemental data

Journal Articles

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

Zachary Davis, Martin Felices, Todd Lenvik, Sujan Badal, Joshua T. Walker, Peter Hinderlie, James L. Riley, Daniel A. Vallera, Bruce R. Blazar, Jeffrey S. Miller

Blood Adv (2021) 5 (4): 1069–1080.

https://doi.org/10.1182/bloodadvances.2019001110

Published: 2021

Includes: Supplemental data

Journal Articles

Naive T-cell depletion in stem cell transplantation

Marie Bleakley

Blood Adv (2020) 4 (19): 4980.

https://doi.org/10.1182/bloodadvances.2020001888

Published: 2020

Includes: Supplemental data

Journal Articles

Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma

Kodandaram Pillarisetti, Gordon Powers, Leopoldo Luistro, Alexander Babich, Eric Baldwin, Yingzhe Li, Xiaochun Zhang, Mark Mendonça, Nate Majewski, Rupesh Nanjunda, Diana Chin, Kathryn Packman, Yusri Elsayed, Ricardo Attar, François Gaudet

Blood Adv (2020) 4 (18): 4538–4549.

https://doi.org/10.1182/bloodadvances.2020002393

Published: 2020

Includes: Supplemental data

NARROW

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

A novel activating JAK1 mutation in chronic eosinophilic leukemia

Germline variants in DNA repair genes, including BRCA1 / 2 , may cause familial myeloproliferative neoplasms

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis

A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome

Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer

Functional characterization of PD1 + TIM3 + tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade

Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myeloma

Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles

A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

Naive T-cell depletion in stem cell transplantation

Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only